We are live on
!
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$157M
1-Year Est. Return
46.57%
This Fund
S&P 500
This Quarter
Est. Return
+15.4%
1 Year Est. Return
+46.57%
3 Year Est. Return
+102.93%
5 Year Est. Return
+150.44%
10 Year Est. Return
–
AUM
$115M
AUM Growth
+$13.7M
(+13%)
Cap. Flow
+$3M
Cap. Flow
% of AUM
2.6%
Top 10 Holdings %
Top 10 Hldgs %
41.79%
Holding
107
New
4
Increased
71
Reduced
10
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MOBL
MobileIron, Inc.
MOBL
|
+$828K |
| 2 |
CEMI
Chembio diagnostics, Inc.
CEMI
|
+$571K |
| 3 |
Moody's
MCO
|
+$571K |
| 4 |
MESO
Mesoblast
MESO
|
+$319K |
| 5 |
PIM
Franklin Master Intermediate Income Trust
PIM
|
+$296K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cerence
CRNC
|
+$1.06M |
| 2 |
CryoPort
CYRX
|
+$756K |
| 3 |
Peloton Interactive
PTON
|
+$501K |
| 4 |
Abbott
ABT
|
+$351K |
| 5 |
John Wiley & Sons Class A
WLY
|
+$242K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.78% |
| 2 | Healthcare | 18.61% |
| 3 | Consumer Discretionary | 10.2% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.62T
| $9.02M | 7.82% |
42,876
+1,320
| +3% | +$277K |
|
|
NVO
2
Novo Nordisk
NVO
$208B
| $8.81M | 7.63% |
253,700
+1,000
| +0.4% | +$33.3K |
|
3
Amazon
AMZN
$3.06T
| $8.03M | 6.96% |
51,000
| – | – |
|
|
MESO
4
Mesoblast
MESO
$1.88B
| $4.61M | 3.99% |
123,925
+10,175
| +9% | +$319K |
|
|
5
Moody's
MCO
$83.7B
| $4.49M | 3.89% |
15,500
+2,000
| +15% | +$571K |
|
|
6
Cerence
CRNC
$403M
| $3.19M | 2.77% |
65,320
-22,086
| -25% | -$1.06M |
|
7
Orion Energy Systems
OESX
$41.5M
| $2.85M | 2.47% |
37,596
+2,200
| +6% | +$120K |
|
8
Thomson Reuters
TRI
$44.4B
| $2.59M | 2.25% |
30,853
+1,722
| +6% | +$134K |
|
9
Alphabet (Google) Class C
GOOG
$4.56T
| $2.37M | 2.05% |
32,220
+2,000
| +7% | +$153K |
|
|
10
Alphabet (Google) Class A
GOOGL
$4.57T
| $2.25M | 1.95% |
30,700
+2,000
| +7% | +$152K |
|
11
Apple
AAPL
$4.43T
| $1.97M | 1.71% |
17,016
-620
| -4% | -$67.7K |
|
12
Azenta
AZTA
$1.38B
| $1.88M | 1.63% |
40,720
+2,485
| +6% | +$120K |
|
|
NUAN
13
DELISTED
Nuance Communications, Inc.
NUAN
| $1.86M | 1.61% |
55,990
+4,100
| +8% | +$119K |
|
|
CYBE
14
DELISTED
Cyberoptics Corp
CYBE
| $1.84M | 1.6% |
57,940
+3,140
| +6% | +$110K |
|
15
Verizon
VZ
$197B
| $1.8M | 1.56% |
30,349
+1,200
| +4% | +$69.7K |
|
16
Sony
SONY
$133B
| $1.76M | 1.53% |
115,000
+5,000
| +5% | +$77.8K |
|
17
Chegg
CHGG
$114M
| $1.75M | 1.52% |
24,495
+1,500
| +7% | +$110K |
|
|
18
CryoPort
CYRX
$781M
| $1.72M | 1.49% |
36,245
-18,675
| -34% | -$756K |
|
|
CEMI
19
DELISTED
Chembio diagnostics, Inc.
CEMI
| $1.67M | 1.44% |
342,760
+120,540
| +54% | +$571K |
|
20
Axcelis
ACLS
$4.03B
| $1.58M | 1.37% |
71,750
+150
| +0.2% | +$3.83K |
|
|
21
Peloton Interactive
PTON
$2.79B
| $1.56M | 1.35% |
15,735
-6,810
| -30% | -$501K |
|
|
ASPU
22
DELISTED
ASPEN GROUP, INC.
ASPU
| $1.53M | 1.32% |
136,720
+5,910
| +5% | +$62.9K |
|
23
Fidelity National Financial
FNF
$13.9B
| $1.5M | 1.3% |
49,992
+520
| +1% | +$16.3K |
|
24
Invesco QQQ Trust
QQQ
$469B
| $1.47M | 1.27% |
5,289
-35
| -0.7% | -$9.49K |
|
25
State Street SPDR S&P 500 ETF Trust
SPY
$806B
| $1.47M | 1.27% |
4,379
| – | – |
|
Similar funds
IWM
EP
AC
SF
LAM
HAM
HEM
CF
Penbrook Management's Q3 2020 Portfolio in Review
As of Q3 2020, Penbrook Management held 107 positions worth $115M, up 13% from $102M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Penbrook Management's Q3 2020 filing shows 4 new, 71 increased, 10 reduced and 6 closed positions. Its largest new stake was MobileIron, Inc.: 141,800 shares worth $994K. The largest sale was Cerence, an estimated $1.06M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Penbrook Management's largest Q3 2020 buy was MobileIron, Inc.: 141,800 shares worth $994K.
- Penbrook Management added most to Chembio diagnostics, Inc. in Q3 2020, an estimated $571K increase.
- Penbrook Management's biggest Q3 2020 reduction was Cerence, cutting an estimated $1.06M.
- Penbrook Management fully exited Abbott in Q3 2020, selling an estimated $351K.
- Penbrook Management's ten largest holdings make up 42% of its $115M portfolio in Q3 2020.
- Penbrook Management opened 4 new positions and closed 6 in Q3 2020.
- Penbrook Management's portfolio value rose 13% quarter-over-quarter to $115M.
Based on Penbrook Management's 13F filing for Q3 2020, filed 23 Oct 2020.